13F HOLDINGS REPORT
STEMPOINT CAPITAL LP
Quarter ended Q3 2024 · Filed November 13, 2024 · Accession 0001420506-24-002386
Total Value
$334.0M
Positions
58
Other Managers
0
Confidential Omitted
No
Holdings (58)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SYNDAX PHARMACEUTICALS INC | SNDX | 1,731,191 | $33.3M | 9.98% |
| 2 | ROIVANT SCIENCES LTD | ROIV | 2,769,819 | $32.0M | 9.57% |
| 3 | MERUS N V | N5749R100 | 421,222 | $21.0M | 6.30% |
| 4 | IMMUNOVANT INC | IMVT | 671,001 | $19.1M | 5.73% |
| 5 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 1,778,318 | $16.5M | 4.95% |
| 6 | AMICUS THERAPEUTICS INC | FOLD | 1,481,809 | $15.8M | 4.74% |
| 7 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 275,303 | $14.2M | 4.26% |
| 8 | APPLIED THERAPEUTICS INC | 03828A101 | 1,554,586 | $13.2M | 3.96% |
| 9 | CRINETICS PHARMACEUTICALS IN | CRNX | 213,815 | $10.9M | 3.27% |
| 10 | BIOHAVEN LTD | BHVN | 216,440 | $10.8M | 3.24% |
| 11 | PRAXIS PRECISION MEDICINES I | PRAX | 174,034 | $10.0M | 3.00% |
| 12 | AUTOLUS THERAPEUTICS PLC | AUTL | 2,616,602 | $9.5M | 2.84% |
| 13 | INCYTE CORP | INCY | 129,490 | $8.6M | 2.56% |
| 14 | DENALI THERAPEUTICS INC | DNLI | 282,050 | $8.2M | 2.46% |
| 15 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 506,978 | $7.1M | 2.11% |
| 16 | ACELYRIN INC | 00445A100 | 1,317,854 | $6.5M | 1.95% |
| 17 | SOLENO THERAPEUTICS INC | SLNO | 123,177 | $6.2M | 1.86% |
| 18 | CABALETTA BIO INC | CABA | 1,278,444 | $6.0M | 1.81% |
| 19 | IMMATICS N.V | IMTX | 449,735 | $5.1M | 1.54% |
| 20 | KEROS THERAPEUTICS INC | KROS | 86,930 | $5.0M | 1.51% |
| 21 | ARCELLX INC | ACLX | 60,076 | $5.0M | 1.50% |
| 22 | NURIX THERAPEUTICS INC | NRIX | 203,015 | $4.6M | 1.37% |
| 23 | TSCAN THERAPEUTICS INC | TCRX | 860,951 | $4.3M | 1.28% |
| 24 | ZURA BIO LTD | ZURA | 1,044,168 | $4.2M | 1.27% |
| 25 | IDEAYA BIOSCIENCES INC | IDYA | 132,703 | $4.2M | 1.26% |
| 26 | TERNS PHARMACEUTICALS INC | TERN | 449,321 | $3.7M | 1.12% |
| 27 | VISTAGEN THERAPEUTICS INC | VTGN | 1,230,043 | $3.7M | 1.11% |
| 28 | PERSPECTIVE THERAPEUTICS INC | CATX | 238,084 | $3.2M | 0.95% |
| 29 | PYXIS ONCOLOGY INC | PYXS | 850,210 | $3.1M | 0.93% |
| 30 | NEUROGENE INC | NGNE | 73,299 | $3.1M | 0.92% |
| 31 | UROGEN PHARMA LTD | URGN | 241,984 | $3.1M | 0.92% |
| 32 | VIGIL NEUROSCIENCE INC | 92673K108 | 743,719 | $2.5M | 0.76% |
| 33 | WAVE LIFE SCIENCES LTD | WVE | 300,000 | $2.5M | 0.74% |
| 34 | BRIDGEBIO PHARMA INC | BBIO | 94,885 | $2.4M | 0.72% |
| 35 | JANUX THERAPEUTICS INC | JANX | 49,415 | $2.2M | 0.67% |
| 36 | SURROZEN INC | SRZNW | 182,918 | $2.2M | 0.66% |
| 37 | RHYTHM PHARMACEUTICALS INC | RYTM | 41,268 | $2.2M | 0.65% |
| 38 | HELIX ACQUISITION CORP II | HLXC | 200,000 | $2.1M | 0.63% |
| 39 | SAREPTA THERAPEUTICS INC | SRPT | 15,014 | $1.9M | 0.56% |
| 40 | PROTARA THERAPEUTICS INC | TARA | 942,857 | $1.7M | 0.52% |
| 41 | PERCEPTIVE CAP SOLUTIONS COR | G70077105 | 150,000 | $1.5M | 0.45% |
| 42 | TOURMALINE BIO INC | 89157D105 | 55,523 | $1.4M | 0.43% |
| 43 | CAPRICOR THERAPEUTICS INC | CAPR | 93,638 | $1.4M | 0.43% |
| 44 | ALKERMES PLC | ALKS | 48,918 | $1.4M | 0.41% |
| 45 | CENTESSA PHARMACEUTICALS PLC | CNTA | 83,662 | $1.3M | 0.40% |
| 46 | MBX BIOSCIENCES INC | MBX | 50,000 | $1.3M | 0.39% |
| 47 | VISTAGEN THERAPEUTICS INC | VTGN | 616,749 | $1.2M | 0.36% |
| 48 | CYTOKINETICS INC | CYTK | 14,464 | $763,699 | 0.23% |
| 49 | REVOLUTION MEDICINES INC | RVMDW | 16,654 | $755,259 | 0.23% |
| 50 | ASTRIA THERAPEUTICS INC | 04635X102 | 56,287 | $618,876 | 0.19% |
| 51 | EDGEWISE THERAPEUTICS INC | EWTX | 19,900 | $531,131 | 0.16% |
| 52 | SYNDAX PHARMACEUTICALS INC | SNDX | 75,000 | $221,250 | 0.07% |
| 53 | SYNDAX PHARMACEUTICALS INC | SNDX | 105,000 | $141,750 | 0.04% |
| 54 | APPLIED THERAPEUTICS INC | 03828A101 | 251,600 | $75,480 | 0.02% |
| 55 | IMMUNOVANT INC | IMVT | 100,000 | $75,000 | 0.02% |
| 56 | IMMUNOVANT INC | IMVT | 100,000 | $37,500 | 0.01% |
| 57 | SYNDAX PHARMACEUTICALS INC | SNDX | 50,000 | $18,750 | 0.01% |
| 58 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 250,000 | $12,500 | 0.00% |